Skip to content

The predictive effect of sarcopenia index on cognitive function in elderly stroke patients

The predictive effect of sarcopenia index on cognitive function in elderly stroke patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074895
Enrollment
Unknown
Registered
2023-08-18
Start date
2023-04-10
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Low SI group/High SI group:NO

Sponsors

Southwest Medical University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the diagnostic criteria for acute ischemic stroke in the ' Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018 '. 2. Elderly population aged = 60 years old; 3. First onset, onset time = 24 h ; 5. Awareness, can cooperate to complete the assessment of sarcopenia, cognitive function ; 6. With the consent of the patient or the guardian, they can cooperate with the follow-up study.

Exclusion criteria

Exclusion criteria: ? Pre stroke functional impairment: improved mRs = 4 points; ? Failure to conduct human component analysis, i.e. implantation of pacemakers or carrying metal or electronic devices within the body; ? The National Institute of Health Stroke Scale (NIHSS) scores = 15; ? Individuals with central nervous system diseases that may lead to cognitive impairment, including degenerative neurological diseases such as Parkinson's disease, Parkinson's syndrome, Alzheimer's disease, hydrocephalus, intracranial tumors, epilepsy, intracranial infections, autoimmune diseases, etc; ? Merge severe primary diseases such as heart, liver, kidney, malignant tumors, neuromuscular conduction disorders or muscle diseases, hematopoietic and endocrine systems; ? Suffering from acute infectious diseases or in the acute stage of chronic infectious diseases; ? Individuals with a history of brain injury, a clear history of stroke, or hemorrhagic cerebrovascular disease.

Design outcomes

Primary

MeasureTime frame
Sarcopenia index;Cognitive function;

Secondary

MeasureTime frame
Activity of daily living;Modified Rankin score;CBC;Biochemical examination;Severity of stroke nerve injury;Aphasia degree;Motor function;

Countries

China

Contacts

Public ContactShengmin Guo

Southwest Medical University Affiliated Hospital

842064313@qq.com+86 139 8025 5653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026